2 transcripts
SLRN
Earnings call transcript
NASDAQ
2024 Q2
13 Aug 24
related to additional financing or partnering.
We are very excited about the milestones ahead for Acelyrin. We remain focused on our core mission
SLRN
Earnings call transcript
NASDAQ
2023 Q2
14 Aug 23
are partnering with us on this mission to accelerate the development and delivery of transformative new medicines to the patients who need them.
We
- Prev
- 1
- Next